Literature DB >> 11412212

Capsaicin receptor VR1 and ATP-gated ion channel P2X3 in human urinary bladder.

Y Yiangou1, P Facer, A Ford, C Brady, O Wiseman, C J Fowler, P Anand.   

Abstract

OBJECTIVES: To determine the presence, distribution and molecular forms of the vanilloid receptor VR1, and confirm the presence and distribution of the ATP-gated ion channel P2X3 in the human urinary bladder. Materials and methods Normal urinary bladder tissues were obtained at postmortem from four subjects. Eight urinary bladder biopsies were also taken from patients with detrusor hyper-reflexia treated with intravesical resiniferatoxin. The specimens were studied using affinity-purified specific antibodies to VR1 and P2X3 by Western blotting and immunocytochemistry, and compared with immunostaining using antibodies to the pan-neuronal marker PGP 9.5 and Schwann cell marker S-100.
RESULTS: VR1- and P2X3-immunoreactive fine nerve fibres were scattered throughout the suburothelium of the normal bladder and cystoscopic biopsies, and traversed the muscle layer. They had a similar distribution to PGP 9.5-immunoreactive fibres, but there were fewer, suggesting localization in subsets of axons. Western blot studies showed an expected 100-kDa VR1 protein and a P2X3-immunoreactive 66-kDa protein. Conclusion VR1 and P2X3 are present in the human urinary bladder and may contribute to distinct pathophysiological states of bladder overactivity, in accord with their differential expression in sensory neurones. Intravesical vanilloids act via VR1 and are effective in the treatment of detrusor hyper-reflexia. P2X3 may represent a selective therapeutic target for other causes of overactive bladder.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11412212     DOI: 10.1046/j.1464-410x.2001.02190.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  37 in total

1.  Vanilloid receptor expression suggests a sensory role for urinary bladder epithelial cells.

Authors:  L A Birder; A J Kanai; W C de Groat; S Kiss; M L Nealen; N E Burke; K E Dineley; S Watkins; I J Reynolds; M J Caterina
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-23       Impact factor: 11.205

Review 2.  From urgency to frequency: facts and controversies of TRPs in the lower urinary tract.

Authors:  Roman Skryma; Natalia Prevarskaya; Dimitra Gkika; Yaroslav Shuba
Journal:  Nat Rev Urol       Date:  2011-10-04       Impact factor: 14.432

3.  Distribution of the vanilloid (capsaicin) receptor type 1 in the human stomach.

Authors:  Maria-Simonetta Faussone-Pellegrini; Antonio Taddei; Elisa Bizzoco; Massimo Lazzeri; Maria Giuliana Vannucchi; Paolo Bechi
Journal:  Histochem Cell Biol       Date:  2005-07-22       Impact factor: 4.304

Review 4.  Pharmacology of P2X channels.

Authors:  Joel R Gever; Debra A Cockayne; Michael P Dillon; Geoffrey Burnstock; Anthony P D W Ford
Journal:  Pflugers Arch       Date:  2006-04-29       Impact factor: 3.657

Review 5.  TRPV1 (vanilloid receptor) in the urinary tract: expression, function and clinical applications.

Authors:  António Avelino; Francisco Cruz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-05-24       Impact factor: 3.000

Review 6.  Integrated control of lower urinary tract--clinical perspective.

Authors:  Clare J Fowler
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

Review 7.  Defining protein expression in the urothelium: a problem of more than transitional interest.

Authors:  Weiqun Yu; Warren G Hill
Journal:  Am J Physiol Renal Physiol       Date:  2011-08-31

Review 8.  Urothelial signaling.

Authors:  Lori Birder; Karl-Erik Andersson
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

Review 9.  TRP channels in lower urinary tract dysfunction.

Authors:  J Franken; P Uvin; D De Ridder; T Voets
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

Review 10.  The Urothelium: Life in a Liquid Environment.

Authors:  Marianela G Dalghi; Nicolas Montalbetti; Marcelo D Carattino; Gerard Apodaca
Journal:  Physiol Rev       Date:  2020-03-19       Impact factor: 37.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.